Radiotherapy target volume for limited-disease small cell lung cancer: good news from the dark side of the moon

Research Institute of Clinical Medicine, Tbilisi, Georgia, BioIRC R&D Center for Biomedical Research, Kragujevac, Serbia; Clinical Center of Serbia, Belgrade, Serbia Correspondence to: Branislav Jeremic, MD, PhD. Research Institute of Clinical Medicine, 13 Tevdore Mgvdeli St., 0112 Tbilisi, Georgia. Email: nebareje@gmail.com. Provenance and Peer Review: This is an invited article commissioned by the Section Editor Dr. Chun-Ru Chien (Director, Department of Radiation Oncology, China Medical University Hsinchu Hospital, Hsinchu; Professor, Department of Radiation Oncology, China Medical University, Taichung). Comment on: Hu X, Bao Y, Xu YJ, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer 2020;126:840-9.